N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours
Open Access
- 15 April 2001
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 84 (8) , 1107-1114
- https://doi.org/10.1054/bjoc.2000.1713
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- Childhood cancer: A growing problem.Environmental Health Perspectives, 1998
- Angiogenic and Angiostatic Microenvironment in Tumors:Role of GangliosidesActa Oncologica, 1997
- Influence of Host Cell Infiltration on the Glycolipid Content of Mouse Brain TumorsJournal of Neurochemistry, 1996
- Gangliosides modulate proliferation, migration, and invasiveness of human brain tumor cells in vitroMolecular and Chemical Neuropathology, 1995
- Enhanced Aspartate Release from Hippocampal Slices of Epileptic (El) MiceJournal of Neurochemistry, 1991
- PRODUCTION OF BRAIN TUMORS WITH AROMATIC HYDROCARBONSAnnals of the New York Academy of Sciences, 1982
- CEREBRAL, CEREBELLAR, AND BRAIN STEM GANGLIOSIDES IN MICE SUSCEPTIBLE TO AUDIOGENIC SEIZURESJournal of Neurochemistry, 1978
- Effect of the Removal of Cell Surface Sialic Acids on Cell Aggregation in vitroNature, 1968
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957